0000914190-14-000360.txt : 20140820
0000914190-14-000360.hdr.sgml : 20140820
20140820175131
ACCESSION NUMBER: 0000914190-14-000360
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140818
FILED AS OF DATE: 20140820
DATE AS OF CHANGE: 20140820
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cardiovascular Systems Inc
CENTRAL INDEX KEY: 0001180145
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 411698056
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 651 CAMPUS DRIVE
CITY: ST. PAUL
STATE: MN
ZIP: 55112
BUSINESS PHONE: 651-259-1600
MAIL ADDRESS:
STREET 1: 651 CAMPUS DRIVE
CITY: ST. PAUL
STATE: MN
ZIP: 55112
FORMER COMPANY:
FORMER CONFORMED NAME: REPLIDYNE INC
DATE OF NAME CHANGE: 20020813
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Martin David
CENTRAL INDEX KEY: 0001304318
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-52082
FILM NUMBER: 141055794
MAIL ADDRESS:
STREET 1: 651 CAMPUS DRIVE
CITY: ST. PAUL
STATE: MN
ZIP: 55112
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2014-08-18
0001180145
Cardiovascular Systems Inc
CSII
0001304318
Martin David
651 CAMPUS DRIVE
ST. PAUL
MN
55112
1
1
0
0
President and CEO
Common Stock
2014-08-18
4
A
0
28987
0
A
372336
D
Common Stock
2014-08-18
4
A
0
28987
0
A
401323
D
Common Stock
2014-08-18
4
A
0
19325
0
A
420648
D
Common Stock
2014-08-19
4
S
0
11754
29.2793
D
408894
D
Common Stock
850
I
By child
Common Stock
350
I
By child
Common Stock
850
I
By child
Stock Option (right to buy)
8.83
2017-02-14
Common Stock
20800
20800
D
Stock Option (right to buy)
7.90
2017-06-11
Common Stock
90580
90580
D
Stock Option (right to buy)
12.15
2017-12-11
Common Stock
234395
234395
D
Stock Option (right to buy)
8.75
2019-03-01
Common Stock
32350
32350
D
Subject to performance-based forfeiture based on total shareholder return for fiscal 2015 versus the Company's peer group.
Subject to performance-based forfeiture based on annual revenue growth for fiscal 2015 versus the Company's peer group.
Restrictions lapse over a three-year period.
In connection with the vesting and delivery of restricted stock and pursuant to a Rule 10b5-1 trading plan, on the date the shares were sold the net proceeds were used to pay required withholding taxes.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.83 to $29.65 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Fully exercisable.
/s/ Amanda Schmall as Attorney-in-Fact for David L. Martin pursuant to Power of Attorney previously filed.
2014-08-20